Gladstone Home blank GIVI HOME
 
spacer
 
Supporting Gladstone
Publications 1987-1988
  • Bohnlein E, Siekevitz M, Ballard DW, Lowenthal JW, Rimsky L, Bogerd H, Hoffman J, Wano Y, Franza BR, Greene WC. Stimulation of the HIV-1 enhancer by the HTLV-I tax gene product involves the action of inducible cellular proteins. J. Virol. 63:1578–1586, 1988.
  • Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression of the HTLV-I Tax protein in human T cells activates specific cellular genes involved in growth. Proc. Natl. Acad. Sci. USA 85:9733–9737, 1988.
  • Rimsky L, Hauber J, Dukovich M, Malim MH, Langlois A, Cullen BR, Greene WC. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature 335:738–740, 1988.
  • Fung M, Ju G, Greene WC. Cointernalization of the p55 and p70 subunits of the high affinity human IL-2 receptor: evidence for a stable ternary receptor complex. J. Exp. Med. 168 (5): 1923–1928, 1988.
  • Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I Tax induces a cellular protein(s) that activates a kB element in the IL-2 receptor alpha gene. Science 141:1652–1655, 1988.
  • Froussard P, Chastagner P, Somme G, Abadie A, Greene WC, Theze J, Longacre S. p55 IL-2 receptor mRNA precursors in murine T lymphocyte nuclei. J. Immunol. 141:1358–1364, 1988.
  • Collins L, Tsien W-h, Seals C, Hakimi J, Weber D, Bailon P, Hosking J, Greene WC, Toome V, Ju G. Identification of specific residues of human interleukin-2 that affect binding to the 70-kDa subunit (p70) of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 85:7709–7713, 1988.
  • Bohnlein E, Lowenthal JW, Siekevitz M, Ballard DW, Franza BR, Greene WC. The same inducible nuclear protein(s) regulate mitogen activation of both the interleukin-2 receptor-alpha gene and type I human immunodeficiency virus. Cell 53:827–836, 1988.
  • Lowenthal JW, Bohnlein E, Ballard DW, Greene WC. Regulation of interleukin-2 receptor alpha subunit (Tac or CD25) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc. Natl. Acad. Sci. USA 85:4468–4472, 1988.
  • Zeitz M, Greene WC, Peffer NJ, James SP. Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T cell activation. Gastroenterology 94:647–655, 1988.
  • Greene WC, Bohnlein E, Siekevitz M, Franza BR, Lowenthal JW. The human interleukin-2 receptor: recent studies of structure and regulation. Ann NY Acad. Sci. 546:116–121, 1988.
  • Bohnlein E, Siekevitz M, Lowenthal JW, Wano Y, Ballard DW, Franza BR, Greene WC. HTLV-I, HIV-1, and T cell activation. In: Franza R, Cullen B, Wong-Staal F (Eds.), The Control of HIV Gene Expression, 1988, pp. 191–202.
  • Kehrl JH, Dukovich M, Whalen G, Katz, Fauci AS, Greene WC. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J. Clin. Invest. 81:200–205, 1988.
  • Greene WC. Sarcoidosis and interleukin-2 receptors (Editorial). In: Amer. Rev. Resp. Dis., 1988, pp. 757–758.
  • Greene WC, Dukovich M, Wano Y, Siekevitz M. HTLV-I, HIV and human T cell growth. In: Banbury Report 30: Eukaryotic Transposable Elements as Mutagenic Agents, Cold Spring Harbor Laboratory, 1988, pp. 309–318.
  • Cullen BR, Podlaski FJ, Peffer NJ, Hosking JB, Greene WC. Sequence requirements of ligand binding and cell surface expression of the Tac antigen, a human interleukin-2 receptor. J. Biol. Chem. 263:4900–4906, 1988.
  • Greene WC, Wano Y, Dukovich M. New insights into the structure of high affinity interleukin-2 receptors. Rec. Progr. in Hormone Res. 44:141–155, 1988.
  • Greene WC. The molecular biology of the human interleukin-2 receptor. In: Poste G, Crooke ST (Eds.), Proceedings of the Smith, Kline and French Research Symposium V "Cellular and Molecular Aspects of Inflammation," 1988, pp. 381–402.
  • Wano Y, Dukovich M, Kehrl JH, Greene WC. New perspectives on the structure of the human high affinity interleukin-2 receptor. In: Smith KA (Ed.), Interleukin 2, Academic Press, New York, 1988, pp. 99–112.
  • Greene WC. IL-2, IL-2 receptors, and the growth of human T-cells: In: Gallin J, Goldstein I, Snyderman R (Eds.), Inflammation: Basic Principles and Clinical Correlations, Raven Press, New York, 1988, pp. 209–228.
  • Greene WC. Expression of interleukin-2 receptors in normal and neoplastic T cells. Int. J. Immunotherapy III 3:171–175 1987.
  • Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, Greene WC. Activation of the HIV-1 LTR by T-cell mitogens and the transactivator protein of HTLV-I. Science 238:1575–1578, 1987.
  • Lowenthal JL, Greene WC. Contrasting interleukin-2 binding properties of the a (p55) and b (p70) protein subunits of the human high affinity IL-2 receptor. J. Exp. Med. 166:1156–1161, 1987.
  • Rubin LA, Hoekzema GS, Nelson DL, Greene WC, Jay G. Reconstitution of a functional interleukin-2 receptor in a non-lymphoid cell. J. Immunol. 139:2355–2360, 1987.
  • Wano Y, Hattori T, Matsuoka M, Chua AO, Gubler U, Takatsuki K, Greene WC. Interleukin-1 gene expression in adult T cell leukemia. J. Clin. Invest. 80:911–916, 1987.
  • Greene WC. The human interleukin-2 receptor: A molecular and biochemical analysis of structure and function. Clinical Research 35: 439–450, 1987.
  • Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC. Direct activation of human resting T cells by IL-2: the role of an IL-2 receptor distinct from the Tac protein. J. Immunol. 139:1550–1559, 1987.
  • Siekevitz M, Feinberg MB, Holbrook N, Yodoi J, Wong-Staal F, Gallo RC, Greene WC. Activation of interleukin-2 and interleukin-2 receptor promoter expression by the transactivator (tat) gene product of HTLV-I. Proc. Natl. Acad. Sci. USA 84: 5389–5394, 1987.
  • Wano Y, Cullen CR, Svetlik PA, Peffer NJ, Greene WC. Reconstitution of high affinity IL-2 receptor expression in a human T cell line using a retroviral cDNA expression vector. Mol. Biol. Med. 4:95–109, 1987.
  • Dukovich M, Wano Y, Bich-Thuy LT, Katz P, Cullen CR, Kehrl JH, Greene WC. A second human interleukin-2 binding protein that may be a component of high affinity interleukin-2 receptors. Nature 327:518–522, 1987.
  • Greene WC, Leonard WJ, Wano Y, Svetlik PB, Peffer NJ, Sodroski JG, Rosen CA, Goh W-c, Haseltine WA. Transactivator gene of HTLV-II: interpretation. Science 235:1073, 1987.
  • Greene WC. IL-2, IL-2 receptors and human retroviruses. Proc. Am. Assoc. Can. Res. 28:469–470, 1987.
  • Bernard O, Fazekas de St. Groth B, Greene WC, Ullrich A, Schlessinger JE. High-affinity interleukin-2 binding protein that may be a component of high affinity interleukin-2 receptors. Proc. Natl. Acad. Sci. USA 84:2125–2129, 1987.
  • Greene WC, Dukovich M, Wano Y, Kehrl JH, Robb RJ. The human high affinity for interleukin-2 receptor. In: Webb DR, Pierce CW, Cohen S (Eds.), Proceedings of the Fifth International Lymphokine Workshop, Humana Press, Clifton, New Jersey, 1987, pp. 171–179.
  • Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC, Waldmann TA. Expression of functional IL-2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes. J. Immunol. 138:2917–2922, 1987.
  • Robb RJ, Greene WC. Internalization of interleukin-2 is mediated by the beta chain of the high affinity IL-2 receptor. J. Exp. Med. 165:1201–1206, 1987.
  • Robb RJ, Rusk CM, Yodoi J, Greene WC. An interleukin-2 binding molecule distinct from the Tac protein: analysis of its role in formation of high affinity receptors. Proc. Natl. Acad. Sci. USA 84:2002–2006, 1987.
  • Greene WC, Leonard WJ, Wano Y, Sodroski JG, Rosen CA, Haseltine WA. The transactivator (tat) gene of HTLV-II induces the expression of cellular genes involved in T cell growth. In: Pruzanski W, Seligmann M (Eds.), Clinical Immunology, Elsevier Science Publishers, Amsterdam, The Netherlands, 1987, pp. 213–216.
  • Greene WC, Leonard WJ. The human interleukin-2 receptor. In: Di Sabato G (Ed.), Methods in Enzymology, Vol. 150, Grune and Stratton, 1987, pp. 682–700.
  • Greene WC. An overview of the human interleukin-2 receptor: Molecular, biochemical and functional properites. In Cancer Investigation 5:369–376, 1987.

Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF  
Contact Webmaster | Copyright © The J. David Gladstone Institutes | CMS created by Altrue.com | Admin.